Background. The purpose of this study was to determine the rate of non-adherence to antihypertensive therapy and to investigate factors that may explain this non-adherence. Methods. This is a cross-sectional study conducted from March to December 2017 in two public hospitals in the city of Kara. It included hypertensive patients known to have been on treatment for at least six months, and who were able to provide information to the Girerd self-questionnaire. A survey form was used to collect sociodemographic, clinical and therapeutic data. Results. Of the 216 received patients, 35.2% had good adherence and 64.8% had difficulties in adhering to their treatment (16.7% had minor adherence problems and 48.1% had poor adherence). The low level of education (OR=1.87; 95% CI=1.01-3.44; p=0.04), the short duration of progression (<5 years) of hypertension (OR=2.90; 95% CI=1.62-5.17; p=0.001), lack of financial resources (OR=2.78; 95% CI=1.37-5.64; p=0.04), non-staff status (OR=2.89; 95% CI 1.60-5.20, p<0.001) and the high number of tablets to be taken per day (OR=3.32; 95% CI 1.80-6.10; p≤ 0.001) were predictive factors for treatment non-compliance. Conclusion. Adherence to antihypertensive therapy was low in a hypertensive population in Northern Togo. Low education level, a duration of hypertension evolution of less than five years, lack of financial means, non-civil servant status and high number of tablets were the factors associated with nonadherence to treatment.
Published in | Cardiology and Cardiovascular Research (Volume 5, Issue 4) |
DOI | 10.11648/j.ccr.20210504.20 |
Page(s) | 219-224 |
Creative Commons |
This is an Open Access article, distributed under the terms of the Creative Commons Attribution 4.0 International License (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted use, distribution and reproduction in any medium or format, provided the original work is properly cited. |
Copyright |
Copyright © The Author(s), 2021. Published by Science Publishing Group |
Adherence to Treatment, Hypertension, Semi-urban Environment, North Togo
[1] | P. M. Kearney, M. Whelton, K. Reynolds et al., “Global burden of hypertension: analysis of worldwide data,” Lancet, vol. 365, pp. 217223, 2005. |
[2] | X. Girerd, O. Hanon, B. Pannier et al., “Déterminants de l’hypertension artérielle contrôlée chez les sujets traités par antihypertenseurs en France: Enquête FLAHS 2015,” [Determinants of controlled arterial hypertension in subjects treated with hypertensive drugs in France FLAHS 2015 survey] Annales de cardiologie et d’Angéiologie, vol. 65, pp. 219-222, 2016. |
[3] | M. Giampiero, A. Ettore, A. Marianna et al., “Adherance to antihypertensive medications and cardiovascular morbidity among newly diagnosed hypertensive patients,” Circulation, vol. 120, pp. 1598-1605, 2009. |
[4] | F. Z. Kettani, A. Dragomir, R. Côté et al., “Impact of a better adherance to antihypertensive agents on cerebrovascular disease for primary prevention, ” Stroke, vol. 40, pp. 213-220, 2009. |
[5] | X. Girerd, O. Hanon, B. Pannier et al., “Mise au point d’un calculateur du risque d’inobservance aux traitements antihypertenseurs chez les hypertendus traités: Le calculateur FLAHS Observance,” [Development of a calculator for the risk of non-compliance with antihypertensive treatments in treated hypertensive patients: The FLAHS compliance calculator] Annales de cardiologie et d’Angéiologie, vol. 66, pp 149-153, 2017. |
[6] | J. Koffi, C. Konin, A. Gnaba et al., “Intérêt de l’éducation thérapeutique dans l’observance du traitement antihypertenseur chez le noir Africain,” [Interest of therapeutic education in compliance with antihypertensive treatment in black Africans] Annales de cardiologie et d’Angéiologie, vol. 67, pp. 9-13, 2018. |
[7] | M. S. Ikama, B. M. Nsitou, M. Loumouamou et al., “L'observance médicamenteuse et ses facteurs dans un groupe d'hypertendus congolais,” [Medication compliance and its factors in a group of Congolese hypertensive people] Pan Afr Med J, vol. 15, pp. 121- 126, 2013. |
[8] | K. A. Adoubi, K. F. Diby, R. Nguetta et al., “Facteurs de la mauvaise observance thérapeutique de l'hypertendu en Côte d'Ivoire,” [Factors of poor therapeutic adherence in hypertension patients in Côte d’Ivoire] Rev Int Sc Med, vol. 8, no. 2, pp. 18–22, 2006. |
[9] | M. Pio, S. Baragou, Y. Afassinou et al., “L'observance thérapeutique de l'hypertention artérielle et ses facteurs dans le service de cardiologie CHU Tokoin de Lomé,” [The therapeutic adherence to arterial hypertension and its factors in the cardiology service CHU in Lomé] Pan Afr Med J, vol. 14, pp. 48-56, 2013. |
[10] | C. Konin, M. Adoh, I. Coulibaly et al., “L’observance thérapeutique et ses facteurs chez l’hypertendu noir africain,” [Adherence to therapy and its factors in hypertensive black Africans] Archives des maladies du cœur et des vaisseaux, vol 100, N° 8, pp. 630-634, 2007. |
[11] | X. Girerd, O Hanon, K. Anagnostospoulos et al., “Evaluation de l’observance du traitement antihypertenseur par un questionnaire: mise au point et utilisation dans un service spécialisé,” [Assessment of compliance to antihypertensive treatment by a questionnaire: development and use in a specialized department.] Presse Méd, vol. 30, p. 1044-1048, 2001. |
[12] | UNDP in Togo: réduire l’extrême pauvreté. Rapport 2007. [Reduce extreme poverty. Report 2007]. Available online at: http://www.tg.undp.org/OMD/omd- pauvr.htm. |
[13] | G. Reach, D. Guedj-Meynier, B. Darné et al., “Facteurs associés à la non-observance chez les hommes et chez les femmes hypertendus non contrôlés: étude ODACE,” [Factors associated with no adherence in uncontrolled hypertensive men and women: ODACE study] Annales de cardiologie et d’Angéiologie, vol. 64, p. 222-226, 2015. |
[14] | J. A. Cramer, R. D. Scheyer, R. H. Mattson, “Compliance declines between clinic visits,” Arch intern Med, vol. 150, pp. 1509-1510, 1990. |
[15] | C. STONG, “Patients perception of medication compliance: a mismatch to reality,” Clinicians News, vol. 6 no. 6, pp. 13-6, 2002. |
[16] | A. J. Scheen, D. Giet, “Non observance thérapeutique: Causes, Conséquences, Solutions,” [Non-adherence to therapy: causes, consequences, solutions] Rev Méd Liège, vol. 65, n. 5, pp. 239–245, 2010. |
[17] | G. A. Hamilton, “Measuring adherence in a hypertension clinical trial,” European Journal of Cardiovascular Nursing, vol. 16, pp. 219-228, 2003. |
[18] | S. Wamala, J. Merlo, G. Bostrom et al., “Socioeconomic disadvantage and primary non-adherence with medication in Sweden,” Int J Qual Health Care, vol. 19, pp. 134-40, 2007. |
APA Style
Tchaa Tcherou, Komlavi Yayehd, Machihuede Pio, Doguensaga Borgatia Atta, Mario Abalo Bakai, et al. (2021). Adherence to Antihypertensive Treatment and Associated Factors in Semi-urban Area in North Togo. Cardiology and Cardiovascular Research, 5(4), 219-224. https://doi.org/10.11648/j.ccr.20210504.20
ACS Style
Tchaa Tcherou; Komlavi Yayehd; Machihuede Pio; Doguensaga Borgatia Atta; Mario Abalo Bakai, et al. Adherence to Antihypertensive Treatment and Associated Factors in Semi-urban Area in North Togo. Cardiol. Cardiovasc. Res. 2021, 5(4), 219-224. doi: 10.11648/j.ccr.20210504.20
AMA Style
Tchaa Tcherou, Komlavi Yayehd, Machihuede Pio, Doguensaga Borgatia Atta, Mario Abalo Bakai, et al. Adherence to Antihypertensive Treatment and Associated Factors in Semi-urban Area in North Togo. Cardiol Cardiovasc Res. 2021;5(4):219-224. doi: 10.11648/j.ccr.20210504.20
@article{10.11648/j.ccr.20210504.20, author = {Tchaa Tcherou and Komlavi Yayehd and Machihuede Pio and Doguensaga Borgatia Atta and Mario Abalo Bakai and Tchalla Yowdema Abena and Findibe Damorou}, title = {Adherence to Antihypertensive Treatment and Associated Factors in Semi-urban Area in North Togo}, journal = {Cardiology and Cardiovascular Research}, volume = {5}, number = {4}, pages = {219-224}, doi = {10.11648/j.ccr.20210504.20}, url = {https://doi.org/10.11648/j.ccr.20210504.20}, eprint = {https://article.sciencepublishinggroup.com/pdf/10.11648.j.ccr.20210504.20}, abstract = {Background. The purpose of this study was to determine the rate of non-adherence to antihypertensive therapy and to investigate factors that may explain this non-adherence. Methods. This is a cross-sectional study conducted from March to December 2017 in two public hospitals in the city of Kara. It included hypertensive patients known to have been on treatment for at least six months, and who were able to provide information to the Girerd self-questionnaire. A survey form was used to collect sociodemographic, clinical and therapeutic data. Results. Of the 216 received patients, 35.2% had good adherence and 64.8% had difficulties in adhering to their treatment (16.7% had minor adherence problems and 48.1% had poor adherence). The low level of education (OR=1.87; 95% CI=1.01-3.44; p=0.04), the short duration of progression (Conclusion. Adherence to antihypertensive therapy was low in a hypertensive population in Northern Togo. Low education level, a duration of hypertension evolution of less than five years, lack of financial means, non-civil servant status and high number of tablets were the factors associated with nonadherence to treatment.}, year = {2021} }
TY - JOUR T1 - Adherence to Antihypertensive Treatment and Associated Factors in Semi-urban Area in North Togo AU - Tchaa Tcherou AU - Komlavi Yayehd AU - Machihuede Pio AU - Doguensaga Borgatia Atta AU - Mario Abalo Bakai AU - Tchalla Yowdema Abena AU - Findibe Damorou Y1 - 2021/12/24 PY - 2021 N1 - https://doi.org/10.11648/j.ccr.20210504.20 DO - 10.11648/j.ccr.20210504.20 T2 - Cardiology and Cardiovascular Research JF - Cardiology and Cardiovascular Research JO - Cardiology and Cardiovascular Research SP - 219 EP - 224 PB - Science Publishing Group SN - 2578-8914 UR - https://doi.org/10.11648/j.ccr.20210504.20 AB - Background. The purpose of this study was to determine the rate of non-adherence to antihypertensive therapy and to investigate factors that may explain this non-adherence. Methods. This is a cross-sectional study conducted from March to December 2017 in two public hospitals in the city of Kara. It included hypertensive patients known to have been on treatment for at least six months, and who were able to provide information to the Girerd self-questionnaire. A survey form was used to collect sociodemographic, clinical and therapeutic data. Results. Of the 216 received patients, 35.2% had good adherence and 64.8% had difficulties in adhering to their treatment (16.7% had minor adherence problems and 48.1% had poor adherence). The low level of education (OR=1.87; 95% CI=1.01-3.44; p=0.04), the short duration of progression (Conclusion. Adherence to antihypertensive therapy was low in a hypertensive population in Northern Togo. Low education level, a duration of hypertension evolution of less than five years, lack of financial means, non-civil servant status and high number of tablets were the factors associated with nonadherence to treatment. VL - 5 IS - 4 ER -